Caricamento...
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
Significant progress has been made in the understanding of the underlying cancer biology of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling pathway remaining implicated throughout the prostate cancer disease continuum. Reactivation of the AR signalling pathway...
Salvato in:
| Pubblicato in: | BJU Int |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744713/ https://ncbi.nlm.nih.gov/pubmed/25818596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13123 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|